Cargando…
P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431362/ http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06 |
_version_ | 1785091182461714432 |
---|---|
author | Watts, Justin M. Hunter, Anthony M. Iurlo, Alessandra Xicoy, Blanca Palandri, Francesca Reeves, Brandi Vannucchi, Alessandro Bose, Prithviraj Ayala Diaz, Rosa Halpern, Anna B. Chen, Xuejun Seguy, Francis Zhou, Feng Zheng, Fred Vachhani, Pankit |
author_facet | Watts, Justin M. Hunter, Anthony M. Iurlo, Alessandra Xicoy, Blanca Palandri, Francesca Reeves, Brandi Vannucchi, Alessandro Bose, Prithviraj Ayala Diaz, Rosa Halpern, Anna B. Chen, Xuejun Seguy, Francis Zhou, Feng Zheng, Fred Vachhani, Pankit |
author_sort | Watts, Justin M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104313622023-08-17 P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY Watts, Justin M. Hunter, Anthony M. Iurlo, Alessandra Xicoy, Blanca Palandri, Francesca Reeves, Brandi Vannucchi, Alessandro Bose, Prithviraj Ayala Diaz, Rosa Halpern, Anna B. Chen, Xuejun Seguy, Francis Zhou, Feng Zheng, Fred Vachhani, Pankit Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431362/ http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Watts, Justin M. Hunter, Anthony M. Iurlo, Alessandra Xicoy, Blanca Palandri, Francesca Reeves, Brandi Vannucchi, Alessandro Bose, Prithviraj Ayala Diaz, Rosa Halpern, Anna B. Chen, Xuejun Seguy, Francis Zhou, Feng Zheng, Fred Vachhani, Pankit P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title_full | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title_fullStr | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title_full_unstemmed | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title_short | P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY |
title_sort | p1055: bromodomain and extra-terminal (bet) inhibitor incb057643 (limber-103) in patients (pts) with relapsed or refractory myelofibrosis (r/r mf) and other advanced myeloid neoplasms: a phase 1 study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431362/ http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06 |
work_keys_str_mv | AT wattsjustinm p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT hunteranthonym p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT iurloalessandra p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT xicoyblanca p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT palandrifrancesca p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT reevesbrandi p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT vannucchialessandro p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT boseprithviraj p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT ayaladiazrosa p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT halpernannab p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT chenxuejun p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT seguyfrancis p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT zhoufeng p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT zhengfred p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study AT vachhanipankit p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study |